Agomab Therapeutics
0 followers
About Agomab Therapeutics
Agomab Therapeutics is a biotechnology company focused on developing fibrotic disease therapies, leveraging deep expertise in growth factor biology to target fibrosis across multiple organ systems. The company conducts research and clinical development, including ontunisertib (AGMB-129) and other growth factor–modulating therapies, with an emphasis on gastrointestinal and other fibrotic conditions. Headquartered in Antwerp, Belgium, Agomab integrates translational science with a patient-centered mission to restore organ function.